We are live on ! Find out more
ECYT

Endocyte, Inc. Common Stock
ECYT

Delisted

ECYT was delisted on the 20th of December, 2018.

Back to rankings

111 hedge funds and large institutions have $216M invested in Endocyte, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 111 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more call options, than puts

Call options by funds: $1.55M | Put options by funds: $822K

Holders
111
Holders Change
+111
Holders Change %
–
% of All Funds
3.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
111
Increased
–
Reduced
–
Closed
–
Calls
$1.55M
Puts
$822K
Net Calls
+$732K
Net Calls Change
+$732K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.84M +$1.89M +140,280 New
Invesco
27
Invesco
Georgia
$1.63M +$1.67M +124,103 New
HCMT
28
Highland Capital Management (Texas)
Texas
$1.59M +$1.63M +120,909 New
Arrowstreet Capital
29
Arrowstreet Capital
Massachusetts
$1.54M +$1.59M +117,625 New
SIM
30
Spark Investment Management
New York
$1.53M +$1.59M +117,600 New
Wellington Management Group
31
Wellington Management Group
Massachusetts
$1.51M +$1.55M +115,145 New
B
32
Bailard
California
$1.43M +$1.47M +109,100 New
Morgan Stanley
33
Morgan Stanley
New York
$1.38M +$1.41M +104,731 New
CTA
34
Chesley Taft & Associates
Illinois
$1.34M +$1.38M +102,000 New
Allianz Asset Management
35
Allianz Asset Management
Germany
$1.33M +$1.36M +101,200 New
TC
36
TFS Capital
Pennsylvania
$1.14M +$1.17M +86,516 New
BIM
37
BlackRock Investment Management
Delaware
$1.06M +$1.09M +80,956 New
TAM
38
Tocqueville Asset Management
New York
$983K +$1.01M +74,875 New
Charles Schwab
39
Charles Schwab
California
$979K +$957K +70,982 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$906K +$930K +69,000 New
PA
41
Perceptive Advisors
New York
$903K +$928K +68,806 New
EI
42
EAM Investors
California
$855K +$878K +65,081 New
IGIM
43
I.G. Investment Management
Manitoba, Canada
$853K +$876K +65,000 New
WA
44
Wasatch Advisors
Utah
$843K +$866K +64,242 New
Wells Fargo
45
Wells Fargo
California
$838K +$862K +63,903 New
CS
46
Credit Suisse
Switzerland
$811K +$833K +61,768 New
TCM
47
Tekla Capital Management
Massachusetts
$790K +$812K +60,200 New
OAM
48
Oxford Asset Management
United Kingdom
$763K +$783K +58,094 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$697K +$716K +53,091 New
RFC
50
Russell Frank Company
Washington
$671K +$689K +51,100 New
1
2
3 4 5

ECYT Hedge Fund Activity: Q2 2013 in Review

111 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Endocyte, Inc. Common Stock (ECYT) for Q2 2013, worth a combined $216M.

Buyers outnumbered sellers: 111 funds opened new ECYT positions and 0 closed out — a net gain of 111 holders — while 0 added to existing stakes and 0 trimmed.

  • 111 institutional investors held Endocyte, Inc. Common Stock (ECYT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $216M of Endocyte, Inc. Common Stock stock for Q2 2013.
  • 111 funds opened new Endocyte, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +111 holders.

Based on aggregated 13F filings for Q2 2013.